Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Due to their rapid and uncontrolled proliferation, cancer cells are characterized by overexpression of glutathione (GSH), which impairs reactive oxygen species (ROS)-based therapy and weakens the chemotherapeutic agent-induced toxification. Extensive efforts have been made in the past few years to improve therapeutic outcomes by depleting intracellular GSH. Special focus has been given to the anticancer applications of varieties of metal nanomedicines with GSH responsiveness and exhaustion capacity. In this review, we introduce several GSH-responsive and -exhausting metal nanomedicines that can specifically ablate tumors based on the high concentration of intracellular GSH in cancer cells. These include inorganic nanomaterials, metal-organic frameworks (MOFs), and platinum-based nanomaterials. We then discuss in detail the metal nanomedicines that have been extensively applied in synergistic cancer therapy, including chemotherapy, photodynamic therapy (PDT), sonodynamic therapy (SDT), chemodynamic therapy (CDT), ferroptotic therapy, and radiotherapy. Finally, we present the horizons and challenges in the field for future development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Stockwell, B. R. (2022) · Cell · doi:10.1016/j.cell.2022.06.003 · Cited by 3,056 · cited 1×
“Concretely, GPX4 uses GSH as the substrate to reduce phospholipid hydroperoxides (PLOOHs) to hydroxyl derivatives (PLOHs), and oxidizes GSH to GSSH, therefore alleviating the damage of oxidative stress to tumor cells (Stockwell, 2022).”
BackgroundBroadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897 · cited 1×
“Researchers have revealed that the morphological characteristics of ferroptosis are the diminishment of mitochondrial volume, the augmentation of membrane density, and the disappearance of mitochondria (Chen et al., 2021).”
BackgroundGlutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636 · cited 1×
“For example, in order to maintain intracellular redox homeostasis and build a powerful antioxidant defense, cancer cells are typically characterized by high level of antioxidants, especially GSH with a high concentration of ~10 mM, which is approximately ten times higher than that in normal cells (Forman et al., 2009).”
BackgroundJohnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485 · cited 1×
“However, their therapeutic outcomes are limited because of drug resistance due to the intracellular inactivation effect (Johnstone et al., 2016).”
BackgroundReactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443 · cited 1×
“Nanotechnology especially has a prominent position in the area of biomedicine, and nanomedicines are being widely explored for the detection, diagnosis, and treatment of cancer (Yang et al., 2019; Huo et al., 2020).”
BackgroundNanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791 · cited 1×
“In the last few years, various GSH modulation-enhanced combinational therapy strategies have been extensively exploited, accompanied by the development of versatile metal-based nanosystems with different structures, functionalities, and treatment performances (Fan et al., 2017).”
BackgroundCisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751 · cited 1×
“As a chemotherapeutic agent, platinum is one of the most widely used metal-based anticancer components (Ghosh, 2019).”
BackgroundMolecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Cited by
New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Wang, C., Zhang, Y., Chen, W., Wu, Y., & Xing, D. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02024-9 · Cited by 188
“This strategy takes advantage of the unique characteristics of tumor cells, such as their increased levels of GSH [86–89].”
BackgroundTumor microenvironment responsive nanozymes for multimodal imaging of tumors
Wang, H., Ouyang, W., & Liu, H. (2024) · Nano TransMed · doi:10.1016/j.ntm.2024.100032 · Cited by 67
Roy, N., & Paira, P. (2024) · ACS Omega · doi:10.1021/acsomega.3c08890 · Cited by 63
“Two enzymatic steps are involved in the consumption of one molecule of ATP for each catalytic cycle, where ATP breaks down into adenosine monophosphate (ADP) and Pi, providing energy for the transportation of amino acids and the synthesis of GSH. 72 − 75 It can be highlighted that synthesis of GSH is governed by three…”
BackgroundInfluentialEmerging trends, and prospects in Nanozyme engineering to enhance dual-mode sensing applications
Singh, R., Sharma, A., Banik, O., Navyatha, B., Santhosh, C., Banoth, E., Balaji, R., Chandrasekar, N., Kumar, S., & Daima, H. K. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216768 · Cited by 54
Nanosensitizer-assisted sonodynamic therapy for breast cancer
Yu, J., Hu, J.-R., Tian, Y., Lei, Y.-M., Hu, H.-M., Lei, B.-S., Zhang, G., Sun, Y., & Ye, H.-R. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03311-3 · Cited by 43
“Hypoxia and high GSH concentrations in the TME make tumors resistant to SDT therapy [61–63].”
Metadata
- Authors
- Liu, P., Hao, L., Liu, M., & Hu, S.
- Affiliations
- Central South University (CN)
- Corresponding author
- Liu, Min
- Hu, Shuo
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-10
- Volume
- 11
- Pages
- 1161472-1161472
- ISSN
- 2296-4185 (ISSN-L)
- PMC
- PMC10036587
- OpenAlex
- W4323857505
- Cited by
- 58
- References
- 95
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Science and Technology Program of Hunan Province
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Materials Chemistry › Advanced Nanomaterials in Catalysis
- Keywords
- glutathione depletion, synergistic cancer therapy, metal-organic frameworks, photodynamic therapy, sonodynamic therapy, chemodynamic therapy, ferroptosis, radiotherapy, reactive oxygen species, chemotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy. https://app.cochat.ai/papers/10.3389/fbioe.2023.1161472
- The paper
- Liu, P., Hao, L., Liu, M., & Hu, S. (2023). Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2023.1161472
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.